The risk-based breast screening (RIBBS) study protocol: a personalized screening model for young women

被引:2
|
作者
Gennaro, Gisella [1 ]
Bucchi, Lauro [2 ]
Ravaioli, Alessandra [2 ]
Zorzi, Manuel [3 ]
Falcini, Fabio [2 ,4 ]
Russo, Francesca [5 ]
Caumo, Francesca [1 ]
机构
[1] Veneto Inst Oncol IOV IRCCS, Padua, Italy
[2] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amador, Romagna Canc Inst, Emilia Romagna Canc Registry, Meldola, Forli, Italy
[3] Azienda Zero, SER Serv Epidemiol Reg & Registri, Padua, Italy
[4] Local Hlth Author, Canc Prevent Unit, Forli, Italy
[5] Direz Prevenz Sicurezza Alimentare Vet, Reg Veneto, Venice, Italy
来源
RADIOLOGIA MEDICA | 2024年 / 129卷 / 05期
关键词
Breast cancer; Cancer screening; Breast density; Risk assessment; Digital Breast Tomosynthesis; PRECISION MEDICINE; COST-EFFECTIVENESS; CANCER; PROGRAM; DENSITY; STAGE; PERFORMANCE; PREDICTION; INTERVAL;
D O I
10.1007/s11547-024-01797-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The optimal mammography screening strategy for women aged 45-49 years is a matter of debate. We present the RIBBS study protocol, a quasi-experimental, prospective, population-based study comparing a risk- and breast density-stratified screening model (interventional cohort) with annual digital mammography (DM) screening (observational control cohort) in a real-world setting. The interventional cohort consists of 10,269 women aged 45 years enrolled between 2020 and 2021 from two provinces of the Veneto Region (northen Italy). At baseline, participants underwent two-view digital breast tomosynthesis (DBT) and completed the Tyrer-Cuzick risk prediction model. Volumetric breast density (VBD) was calculated from DBT and the lifetime risk (LTR) was estimated by including VBD among the risk factors. Based on VBD and LTR, women were classified into five subgroups with specific screening protocols for subsequent screening rounds: (1) LTR <= 17% and nondense breast: biennial DBT; (2) LTR <= 17% and dense breast: biennial DBT and ultrasound; (3) LTR 17-30% or LTR > 30% without family history of BC, and nondense breast: annual DBT; (4) LTR 17-30% or > 30% without family history of BC, and dense breast: annual DBT and ultrasound; and (5) LTR > 30% and family history of BC: annual DBT and breast MRI. The interventional cohort is still ongoing. An observational, nonequivalent control cohort of 43,000 women aged 45 years participating in an annual DM screening programme was recruited in three provinces of the neighbouring Emilia-Romagna Region. Cumulative incidence rates of advanced BC at three, five, and ten years between the two cohorts will be compared, adjusting for the incidence difference at baseline.
引用
收藏
页码:727 / 736
页数:10
相关论文
共 50 条
  • [31] Organizational challenges to equity in the delivery of services within a new personalized risk-based approach to breast cancer screening
    Levesque, Emmanuelle
    Hagan, Julie
    Knoppers, Bartha M.
    Simard, Jacques
    NEW GENETICS AND SOCIETY, 2019, 38 (01) : 38 - 59
  • [32] Cost of breast cancer screening in the USA: Comparison of current practice, advocated guidelines, and a personalized risk-based approach
    Badal, Kimberly
    Staib, James
    Tice, Jeffrey
    Kim, Mi-Ok
    Eklund, Martin
    Byfield, Stacey DaCosta
    Catlett, Kierstin
    Wilson, Leslie
    Maffey, Liz
    Soonavala, Rashna
    Stover-Fiscalini, Allison
    Esserman, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial
    Shieh, Yiwey
    Eklund, Martin
    Madlensky, Lisa
    Sawyer, Sarah D.
    Thompson, Carlie K.
    Fiscalini, Allison Stover
    Ziv, Elad
    van't Veer, Laura J.
    Esserman, Laura J.
    Tice, Jeffrey A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (05):
  • [34] My PeBS (My Personal Breast Screening): A European clinical study evaluating a personalised risk-based screening strategy
    Delaloge, Suzette
    Balleyguier, Corinne
    IMAGERIE DE LA FEMME, 2019, 29 (01) : 1 - 3
  • [35] Following the High-Risk Patient: Breast Cancer Risk-Based Screening
    Christine L. Klassen
    Lyndsay D. Viers
    Karthik Ghosh
    Annals of Surgical Oncology, 2024, 31 : 3154 - 3159
  • [36] Following the High-Risk Patient: Breast Cancer Risk-Based Screening
    Klassen, Christine L.
    Viers, Lyndsay D.
    Ghosh, Karthik
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (05) : 3154 - 3159
  • [37] Risk-Based Prostate Cancer Screening
    Zhu, Xiaoye
    Albertsen, Peter C.
    Andriole, Gerald L.
    Roobol, Monique J.
    Schroder, Fritz H.
    Vickers, Andrew J.
    EUROPEAN UROLOGY, 2012, 61 (04) : 652 - 661
  • [38] Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM)
    Che, Mandy
    Fiscallini, Allison Stover
    Acerbi, Irene
    Shieh, Yiweh
    Madlensky, Lisa
    Tice, Jeffrey
    Ziv, Elad
    Eklund, Martin
    Blanco, Amie
    Tong, Barry
    Goodman, Deborah
    Nassereddine, Lamees
    Anderson, Nancy
    Harvey, Heather
    Fors, Steele
    Park, Hannah L.
    Petruse, Antonia
    Stewart, Skye
    Wernisch, Janet
    Risty, Larissa
    Hurley, Ian
    Koenig, Barbara
    Kaplan, Celia
    Hiatt, Robert
    Wenger, Neil
    Lee, Vivian
    Heditsian, Diane
    Brain, Susie
    Sabacan, Leah
    Parker, Barbara
    Borowsky, Alexander
    Anton-Culver, Hoda
    Anton-Culver, Hoda
    Naeim, Arash
    Kaster, Andrea
    Talley, Melinda
    van't Veer, Laura
    LaCroix, Andrea
    Olopade, Olufunmilayo I.
    Sheth, Deepa
    Esserman, Laura
    CANCER RESEARCH, 2020, 80 (04)
  • [39] Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM)
    Acerbi, Irene
    Fiscalini, Allison Stover
    Che, Mandy
    Shieh, Yiwey
    Madlensky, Lisa
    Tice, Jeffrey
    Ziv, Elad
    Eklund, Martin
    Blanco, Amie
    Tong, Barry
    Goodman, Deborah
    Nassereddine, Lamees
    Anderson, Nancy
    Harvey, Heather
    Fors, Steele
    Park, Hannah L.
    Petruse, Antonia
    Stewart, Skye
    Wernisch, Janet
    Risty, Larissa
    Hurley, Ian
    Koenig, Barbara
    Kaplan, Celia
    Hiatt, Robert
    Wenger, Neil
    Lee, Vivian
    Heditsian, Diane
    Brain, Susie
    Sabacan, Leah
    Wang, Tianyi
    Parker, Barbara A.
    Borowsky, Alexander
    Anton-Culver, Hoda
    Naeim, Arash
    Kaster, Andrea
    Talley, Melinda
    van 't Veer, Laura
    LaCroix, Andrea Z.
    Olopade, Olufunmilayo I.
    Sheth, Deepa
    Garcia, Augustin
    Lancaster, Rachel
    Esserman, Laura
    CANCER RESEARCH, 2021, 81 (04)
  • [40] Personalized Breast Cancer Screening in a Population-based Study: Women Informed to Screen Depending On Measures of risk (WISDOM)
    Choy, Patricia
    Soonavala, Rashna
    Lewis, Tomiyuri
    Leggat-Barr, Katherine
    Sabacan, Leah
    Fiscalini, Allison Stover
    Van ' T Veer, Laura
    Hererra, Mary
    Goodman, Steff
    Scheuner, Maren
    Sales, Paloma
    Shieh, Yiwey
    Madlensky, Lisa
    Tice, Jeffrey
    Ziv, Elad
    Eklund, Martin
    Blanco, Amie
    Tong, Barry
    Goodman, Deborah
    Park, Hannah Lui
    Palmieri, Marcelo
    Petruse, Antonia
    Wernisch, Janet
    Risty, Larissa
    James, Jennifer
    Kaplan, Celia
    Hiatt, Robert A.
    Rhoads, Kim
    Wenger, Neil
    Lee, Vivian
    Heditsian, Diane M.
    Brain, Susie
    Parker, Barbara
    Borowsky, Alexander
    Anton-Culver, Hoda
    Naeim, Arash
    Kaster, Andrea
    LaCroix, Andrea Z.
    Olopade, Olufunmilayo I.
    Garcia, Agustin
    Lancaster, Rachel B.
    Plaza, Michael
    Moorehead, Dolores
    Esserman, Laura J.
    Rao, Sohail
    CANCER RESEARCH, 2023, 83 (05)